Rottem M, Okada T, Goff JP, Metcalfe DD. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population. Blood. 1994;84:2489–96.

Article  CAS  PubMed  Google Scholar 

Kempuraj D, Saito H, Kaneko A, Fukagawa K, Nakayama M, Toru H, et al. Characterization of mast cell-committed progenitors present in human umbilical cord blood. Blood. 1999;93:3338–46.

Article  CAS  PubMed  Google Scholar 

Gonzalez-de-Olano D, Álvarez-Twose I. Mast cells as key players in allergy and inflammation. J Investig Allergol Clin Immunol. 2018;28:365–78.

Article  CAS  PubMed  Google Scholar 

Valent P, Akin C, Arock M, Brockow K, Butterfield JH, Carter MC, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol. 2012;157:215–25.

Article  PubMed  Google Scholar 

Valent P. Mast cell activation syndromes: definition and classification. Allergy. 2013;68:417–24.

Article  CAS  PubMed  Google Scholar 

Akin C, Valent P, Metcalfe DD. Mast cell activation syndrome: proposed diagnostic criteria. J Allergy Clin Immunol. 2010;126:1099-104.e4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

• Valent P, Akin C, Nedoszytko B, Bonadonna P, Hartmann K, Niedoszytko M, et al. Diagnosis, classification and management of mast cell activation syndromes (MCAS) in the era of personalized medicine. Int J Mol Sci. 2020;21:1–14. Current description of MC activation symptoms and underlying mechanisms, MCAS classification, and differential diagnosis.

Akin C, Scott LM, Kocabas CN, Kushnir-Sukhov N, Brittain E, Noel P, et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with “idiopathic” anaphylaxis. Blood. 2007;110:2331–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sonneck K, Florian S, Mullauer L, Wimazal F, Fodinger M, Sperr WR, et al. Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome. Int Arch Allergy Immunol. 2007;142:158–64.

Article  PubMed  Google Scholar 

• Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo K, Kvasnicka H, et al. Arber. International consensus classification of myeloid neoplasms and acute leukemias integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200–28. Updated guide to the main hematopoietic diseases, including mastocytosis and their diagnostic criteria.

Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol. 2008;122:1161–5.

Article  PubMed  PubMed Central  Google Scholar 

Simons FER, Peterson S, Black CD. Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol. 2002;110:647–51.

Article  PubMed  Google Scholar 

González-Pérez A, Aponte Z, Vidaurre CF, Rodríguez LAG. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol. 2010;125:1098–105.

Article  PubMed  Google Scholar 

Sheikh A, Hippisley-Cox J, Newton J, Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med. 2008;101:139–43.

Article  PubMed  PubMed Central  Google Scholar 

Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol. 2004;113:536–42.

Article  PubMed  Google Scholar 

Boros CA, Kay D, Gold MS. Parent reported allergy and anaphylaxis in 4173 South Australian children. J Paediatr Child Health. 2000;36:36–40.

Article  CAS  PubMed  Google Scholar 

Tejedor Alonso MA, Moro Moro M, Múgica García MV, Esteban Hernández J, Rosado Ingelmo A, Vila Albelda C, et al. Incidence of anaphylaxis in the city of Alcorcon (Spain): a population-based study. Clin Exp Allergy. 2012;42:578–89.

CAS  PubMed  Google Scholar 

González-de-Olano D, de-la-Hoz-Caballer B, Núñez-López R, Sánchez-Muñoz L, Cuevas-Agustín M, Diéguez MC, et al. Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish Network on Mastocytosis (REMA). Clin Exp Allergy. 2007;37:1547–55.

Article  PubMed  Google Scholar 

Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008;63:226–32.

Article  CAS  PubMed  Google Scholar 

Gulen T, Hagglund H, Dahlen B, Nilsson G. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience. Clin Exp Allergy. 2014;44:121–9.

Article  CAS  PubMed  Google Scholar 

González-de-Olano D, Esteban-López MI, Alonso-Díaz-de-Durana MD, González-Mancebo E, Prieto-García A, Gandolfo-Cano M, et al. Frequency of clonal mast cell diseases among patients presenting with anaphylaxis: a prospective study in 178 patients from 5 tertiary centers in Spain. J Allergy Clin Immunol Pract. 2019;7:2924-2926.e1.

Article  PubMed  Google Scholar 

Álvarez-Twose I, González-de-Olano D, Sánchez-Muñoz L, Matito A, Esteban-López MI, Vega A, et al. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. J Allergy Clin Immunol. 2010;125:1269-1278.e2.

Article  PubMed  Google Scholar 

González-de-Olano D, Álvarez-Twose I. Insights in anaphylaxis and clonal mast cell disorders. Front Immunol. 2017;8:792.

Article  PubMed  PubMed Central  Google Scholar 

Bonadonna P, Lombardo C, Zanotti R. Mastocytosis and allergic diseases. J Investig Allergol Clin Immunol. 2014;24:288–97; quiz 3 p preceding 297.

CAS  PubMed  Google Scholar 

Bonadonna P, Zanotti R, Muller U. Mastocytosis and insect venom allergy. Curr Opin Allergy Clin Immunol. 2010;10:347–53.

Article  CAS  PubMed  Google Scholar 

Gulen T, Hagglund H, Sander B, Dahlen B, Nilsson G. The presence of mast cell clonality in patients with unexplained anaphylaxis. Clin Exp Allergy. 2014;44:1179–87.

Article  CAS  PubMed  Google Scholar 

Carter MC, Desai A, Komarow HD, Bai Y, Clayton ST, Clark AS, et al. A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis. J Allergy Clin Immunol. 2018;141:180-188.e3.

Article  CAS  PubMed  Google Scholar 

Hartmann K, Escribano L, Grattan C, Brockow K, Carter MC, Álvarez-Twose I, et al. Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology. J Allergy Clin Immunol. 2016;137:35–45.

Article  PubMed  Google Scholar 

Matito A, Azaña JM, Torrelo A, Álvarez-Twose I. Cutaneous mastocytosis in adults and children: new classification and prognostic factors. Immunol Allergy Clin North. 2018;38:351–63.

Article  Google Scholar 

Álvarez-Twose I, Vañó-Galván S, Sánchez-Muñoz L, Morgado JM, Matito A, Torrelo A, et al. Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. Allergy. 2012;67:813–21.

Article  PubMed  Google Scholar 

Schwartz LB, Lewis RA, Austen KF. Tryptase from human pulmonary mast cells. Purification and characterization. J Biol Chem. 1981;256:11939–43.

Article  CAS  PubMed  Google Scholar 

Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med. 1987;316:1622–6.

Article  CAS  PubMed  Google Scholar 

Lee AYS. Elevated serum tryptase in non-anaphylaxis cases: a concise review. Int Arch Allergy Immunol. 2020;181:357–64.

Article  CAS  PubMed  Google Scholar 

Lyons JJ, Yu X, Hughes JD, Le QT, Jamil A, Bai Y, et al. Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nat Genet. 2016;48:1564–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu R, Lyons JJ. Hereditary alpha-tryptasemia: a commonly inherited modifier of anaphylaxis. Curr Allergy Asthma Rep. 2021;21:1–9.

Article  Google Scholar 

Greiner G, Sprinzl B, Górska A, Ratzinger F, Gurbisz M, Witzeneder N, et al. Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis. Blood. 2021;137:238–47.

Article  CAS  PubMed  Google Scholar 

O’Connell MP, Lyons JJ. Hymenoptera venom-induced anaphylaxis and hereditary alpha-tryptasemia. Curr Opin Allergy Clin Immunol. 2020;20:431–7.

Article  PubMed  PubMed Central  Google Scholar 

Robey RC, Wilcock A, Bonin H, Beaman G, Myers B, Grattan C, et al. Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression. J Allergy Clin Immunol Pract. 2020;8:3549–56.

Article  PubMed  Google Scholar 

Chollet MB, Akin C. Hereditary alpha tryptasemia is not associated with specific clinical phenotypes. J Allergy Clin Immunol. 2022;149:728-735.e2.